Back to the feed
In brief
On 15.12.2025, a person holding the function "Non-executive member of the board of directors" at MindMaze Therapeutics Holding SA disclosed a sale worth CHF 412’000 to SIX Exchange Regulation.
This is the largest management sale disclosed at MindMaze Therapeutics Holding SA over the previous 12 months (42 sales in total).
insider24.ch
Never miss a market signal again
Create a free account
Need more? Discover the Pro plan
Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open
Disclosure detail
A non-executive member of the board of directors of MindMaze Therapeutics Holding SA declared a "Sale" transaction on 15.12.2025.
SIX publishes the manager's function, never their name: no individual is named in management transactions.
Transaction date15.12.2025
Issuing companyMindMaze Therapeutics Holding SA
ISINCH1251125998
Transaction sideSale
Management functionNon-executive member of the board of directors
Security typeRegistered shares
Quantity281’968
Unit priceCHF 1.46
AmountCHF 412’000
ExchangeXSWX
Notification IDT1PCF000B5
Other MindMaze Therapeutics Holding SA insider transactions
- Sale · Non-executive member of the board of directors14.09.2026CHF 10’140
- Sale · Non-executive member of the board of directors19.01.2026CHF 61’606
- Sale · Non-executive member of the board of directors05.01.2026CHF 158’417
- Sale · Non-executive member of the board of directors23.12.2025CHF 146’250
- Sale · Non-executive member of the board of directors22.12.2025CHF 152’504
These figures aggregate public disclosures. They are not investment advice.